sq-11725 has been researched along with lopinavir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| A M Subbaiah, M; Annadurai, M; Arla, R; Bhutani, P; Desai, SD; Desikan, S; Jenkins, SM; Kadow, JF; Krystal, MR; Mandlekar, S; Meanwell, NA; Padmanabhan, S; Ramar, T; Singh, S; Sinha, J; Sinha, S; Sridhar, S; Subramani, L; Subramanian, M; Thakur, M | 1 |
2 other study(ies) available for sq-11725 and lopinavir
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor Atazanavir.
Topics: Administration, Oral; Amino Acids; Animals; Area Under Curve; Atazanavir Sulfate; Biological Availability; Drug Design; Esters; HIV Protease Inhibitors; Humans; Phosphates; Prodrugs | 2019 |